ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Cancer Training Programs Fairing Fairley Well

December 1, 1989

In Brief: NCI Still Undecided Over Small Hospital Segment Of CHOP; Multihospital Proposals Review Nov. 14-15

November 2, 1979

In Brief: Simone Named New Director At St. Jude; Schein To Leave Georgetown For Job At Smith-Kline

September 16, 1983